Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)

China flag China · Delayed Price · Currency is CNY
39.63
+0.08 (0.20%)
May 28, 2025, 2:45 PM CST
-37.36%
Market Cap 6.09B
Revenue (ttm) 3.43B
Net Income (ttm) 372.83M
Shares Out 153.40M
EPS (ttm) 2.46
PE Ratio 16.15
Forward PE n/a
Dividend 0.90 (2.28%)
Ex-Dividend Date Apr 30, 2025
Volume 2,060,466
Average Volume 2,079,983
Open 39.36
Previous Close 39.55
Day's Range 39.09 - 39.84
52-Week Range 39.31 - 66.80
Beta 0.79
RSI 32.46
Earnings Date Aug 15, 2025

About SHA:600976

Jianmin Pharmaceutical Group Co.,Ltd. manufactures and sells medicines in China. It offers medicines and pediatric drugs under the Jianmin, Longmu, and Yekaitai brand name. The company provides OTC, medical, and general health products, as well as consultation service. Jianmin Pharmaceutical Group Co.,Ltd. was founded in 1993 and is headquartered in Wuhan, China. [Read more]

Sector Healthcare
Founded 1993
Employees 2,345
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600976
Full Company Profile

Financial Performance

In 2024, SHA:600976's revenue was 3.50 billion, a decrease of -16.81% compared to the previous year's 4.21 billion. Earnings were 362.18 million, a decrease of -30.54%.

Financial Statements

News

There is no news available yet.